← FDA Drug Approvals (Drugs@FDA)
LIDOCAINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NAL PHARM · Approved 2021-04-29
Drug application
- FDA Application #
ANDA205882- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LIDOCAINE
- Generic name
- Lidocaine
- Active ingredients
- LIDOCAINE
- Dosage form
- PATCH
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- NAL PHARM
- First approval
- 2021-04-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown